EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 25.12
+0.02 (0.08%)
Jul 21, 2026, 12:23 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 108.06 million as of July 21, 2026. Its market cap has decreased by -8.16% in one year.
Market Cap
108.06M
Enterprise Value
96.98M
Revenue
51.56M
Ranking
n/a
PE Ratio
53.42
Stock Price
25.12
ChartMarket Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 108.06M, an increase of 4,652.82%. That is a compound annual growth rate of 18.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 108.06M | -5.68% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 195.34B |
| GSK plc | 76.32B |
| Haleon | 32.88B |
| Smith & Nephew | 9.69B |
| Scancell Holdings | 137.51M |
| Diaceutics | 114.30M |
| INSPECS Group | 98.62M |
| Faron Pharmaceuticals Oy | 91.98M |